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Introduction: The midcheek is considered one of the most important facial area due to its involvement in
mimic expression and communication. Pathology of this district is complex due to the variety of soft
tissue belonging to the face. We propose a surgical simulation, to assess the feasibility of a newminimally
invasive endoscopic approach for midcheek mass removal.
Technical report: This study was performed on four cadavers, at the Anatomy Laboratory of the University
of Tubingen. In all the cadavers 3 cm3 of Acquasil Dent Sply Ultra were injected via trans-cutaneous along
the nasolabial fold to simulate a midcheek mass. Three incisions in concealed areas were performed to
create an access to reach the anterior compartment of the face. By using the Optical Dissector with distal
spatula and a 30 endoscope we provided a wide surgical window and a greater exposure to isolate,
dissect and remove the midcheek tumor model safely.
Conclusion: The proposed endoscopic technique allowed us to visualize and preserve all the key
anatomic structures of the midcheek region. Due to its nature, the suggested material may provide a valid
tumor model for surgical training also in other districts.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
The midcheek is considered one of the most important facial
area due to its involvement in mimic expression and communica-
tion [1].
This area has a trapezoidal shape, comprehended between the
lower eyelid above and the upper lip below; limited laterally by a
line extending from the lateral canthus of the orbit to the labial
commissure, medially by a line extending from the internal canthus
to nasolabial fold. In this small area there are many important
structures such as the Zigomatic nerve, the Buccal nerve, the
Accessory parotid Gland, the Stensen's duct (Fig. 1).
Pathology of this district is complex due to the variety of soft
tissue belonging to the face, including skin, lymphatic, adnexal,
neurogenic, and salivary structures [2]. The lesions arising from the
midcheek area are rare and usually arise from the accessory parotidacial surgery, University of
y.
ta).gland [3].
For all these reasons is very important to choose the best sur-
gical approach to remove the soft tissue masses avoiding major
complications, such as hemorrhages, facial paralysis, laceration of
Stensen's duct and unaesthetic scars.
In literature different approaches to remove midcheek masses
are proposed. Most common approaches are: the intraoral, external
(Blair's incision or Face-lift incision), direct skin incision [4,5].
Nevertheless none of them can be considered reliable for the
complete excision of tumor from midcheek with a very low
morbidity, acceptable scare and preservation of the key anatomical
structures. Thus the best surgical approach to this area should
consider both: clinical outcome and aesthetic; the endoscopic
surgery could be a good alternative to the standard procedures. A
recent paper described the endoscopic anatomy of the midcheek
region emphasizing the role of the facial retaining ligaments (FRL)
and in particular of the transverse facial artery (TFA) to guide the
endoscopic dissection to this district safely [6]. Basing to this study
we propose a surgical simulation on cadaver, to assess the feasi-
bility of a new minimally invasive endoscopic approach for
Fig. 1. Midcheek area: PreZ, prezygomatic space; ZN, zygomatic nerve; BN, buccal
nerve; APGs, accessory parotid glands; BFP, buccal fat pad.
Fig. 2. 1-2-3 ¼ Skin incisions. A ¼ Prezygomatic space and B ¼ premasseteric space
cutaneous projection; a ¼ zygomatic; b ¼ upper masseteric; and c ¼ mandibular
retaining ligament's cutaneous projection.
G. Dell' Aversana Orabona et al. / Surgical Oncology 26 (2017) 286e289 287midcheek mass removal, using a tumor training model.
2. Technical report
This study was performed on four cadavers, prepared with
intravascular injection of colored silicone, at the Anatomy Labora-
tory of the University of Tubingen Medical Center, once approval of
the local ethical institutional board was obtained. Eight procedures
were performed; the dissection was bilateral on each cadaver's
side. There were 3 male and 1 female, the age ranged between 64
and 76 years old, with mean age, 71. The only inclusion criteria was
the age of death, nobody over 80 years old, due to the age related
changes occurring in the midcheek area.
2.1. Preoperative preparations
The head position was placed in lateral rotation. The ﬁrst pro-
cedure was the design of the different areas (Fig. 2).
Before the dissection, in all the cadavers on each side of the face
3 cubic centimeters of Acquasil Dent Sply Ultra LV (Light Viscosity)
(Milford, DE)® were injected via trans-cutaneous along the naso-
labial fold.
All the procedures have been performed with the aid of 4 mm
diameter, 18 cm length rigid, rod lens endoscopes with a 30 vision,
angulation coupled to a high deﬁnition camera and monitors (Karl
Storz, Tuttlingen Germany). Optical dissector (50200 ES), with
distal spatula, fenestrated, large, sharp, to be used with HOPKINS II
telescope; RHINOFORCE II nasal scissors (449201), and BLAKESLAY
nasal Forceps (456000) were adopted to perform all the procedures
(Karl Storz). All dissections were documented by high deﬁnition
camera and AIDA recording system (Karl Storz).
2.2. Surgical dissection procedure
For each side, the head was placed in lateral rotation. Three
incisions in concealed area were required: the ﬁrst with a length of
1,5 to 2 cm at the margin of the tragus, the second incision was
performed along the postauricular crease, and the third incision
was made on the temporal scalp above the hairline.
Incisions were made across tissues to the upper face of thesuperﬁcial musculoaponeurotic system (SMAS) and its continua-
tion, the superﬁcial temporal fascia, in the temporal region, pre-
serving the latter.
This small initial dissection allowed the insertion of the optical
dissector with the distal spatula. Under 30 endoscopic view,
through the tragal incision, the ﬁrst structure encounteredwere the
parotid cutaneous ligaments. These ligaments appeared lax and
easily undergo a blunt dissection by endoscopic scissors.
An about 3.5e4 cm from the tragal access the superior branch of
the transverse facial artery (TFA) was highlighted along a line led
from the tragus to the ala nasi.
This artery comes out of the parenchyma and through the
endoscopic ﬁeld of the view, vertically.
Smooth dissection led cranially to this anatomic landmark,
letting the operators visualize the zygomatic retaining ligaments
and the zygomatic branch of the facial nerve.
Keeping the transverse facial artery as the fundamental endo-
scopic landmark, under endoscopic view, we were able to visualize
and preserve: the zygomatic retaining ligaments (FRL) and the
zygomatic branch of the facial nerve. After the initial dissection we
reached the prezygomatic space. We continued with a smooth
dissection through the premasseter space, and themasseter muscle
was easily visualized. In this space there were key anatomic
structures: the parotid duct, the Accessory parotid glands (incon-
stant), the upper masseteric ligaments and the upper buccal trunk
of the facial nerve (Fig. 3). The midcheek tumor model appeared as
a colored mass causing displacement of surrounding neural and
vascular structures. Due to its nonadhesive nature, the model
afforded us a dissection plane very similar to a real tumor. We were
Fig. 3. Key anatomic structures of the midcheek area: PDuct Parotid duct; TFA
Transverse Facial artery; BN Buccal trunk of facial nerve; Pre Z Prezygomatic space; Pre
M premasseteric space; Tumor model TM.
Table 1
Minimally invasive endoscopic approach to midcheek mass: Pros and cons.
Pros Cons
Best aesthetic result Long learning curve
Magniﬁcation of the key anatomical
structures
Not indicated in malignant
neoplasms
Invisible scars Long operative times
Careful bimanual dissection Bleeding control
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safety trough the tragal incision (Fig. 2. Incision n2) (Video).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.suronc.2017.05.005.3. Results
By using the Optical Dissector with a 30 endoscope we pro-
vided awide surgical windowand a greater exposure.Wewere able
to identify and preserve the key anatomic structures of the mid-
cheek area: the superior branch of the TFA; the zygomatic retaining
ligament; the zygomatic branch of facial nerve; the Stensen's duct;
the upper masseteric ligaments and the upper buccal trunk of the
facial nerve; the prezygomatic and premasseter spaces, and the
buccal fat pad (Fig. 1).
In all the cadavers the midcheek tumor model was easily
identiﬁed, dissected and removed.4. Discussion
The lesions arising from the midcheek area are uncommon, few
cases are reported in literature [4,5,7,8]. Beyond aesthetics, the
midcheek area contains key anatomic structures that may be
interested by benign or malignant neoplasms. Incidentally, lesions
occurring in this district are infrequent and often benign [4,5].
The Accessory Parotid Gland is the most common site of origin
of the tumors in the midcheek area and account 1e8% of all parotid
lesions [4,5,7].
Clinically they appear as progressive enlarging and painless
mass. Diagnosis is made by CT scan or MRI and is conﬁrmed by
FNAC biopsy. Differential diagnosis must exclude: vascular mal-
formations (VMs), benign or malignant lymphadenopathy,
masseter muscle hypertophy, lipomas, neuroﬁbromas, schwan-
noma, neurilemmomas, ﬁbromas, malignant tumor arising from
the muscles or buccal fat pad, sialoceles and sialolithiasis [3,8].
The gold standard treatment for removal of midcheek mass is
represented by open surgery, followed by intraoral approach [2e5].
This approaches are not free from complications: high incidence of
vascular and nerve injury, Stensen's duct lesion and unaesthetic
scar were usually reported. The superﬁcial parotidectomy with a
Blair's incision or a Face lift are the most used incisions [4]. The
intra-oral approach is an alternative procedure described in liter-
ature [5] but is not recommended because it provides inadequateexposure for bleeding control and high risk of facial nerve injury.
Because of the particular features of the district, the best surgical
management should consider both, aesthetic and clinical
outcomes.
The endoscopic procedure can be considered a good approach to
conciliate both needs. This approach could be very helpful for the
removal of small benign neoplasms arising from midcheek region
such as VMs, lipomas or pleomorphic adenoma area [9e11]
(Table 1).
Xie et al. [12]., 2012 ﬁrst described the results of minimally
invasive endoscopic approach for resection of a benign tumor in the
accessory parotid gland. Later, Li et al. [13]. 2013 evaluated the
feasibility of a modiﬁed endoscopic approach with minimal, and
concealed, incisions for the resection of benign tumors in the
accessory parotid gland.
Despite the originality of the endoscopic approaches proposed
none of them has provided an optimal technical description.
Thus We propose a cadaveric tested study to assess a new
minimally invasive endoscopic approach to midcheek.
Inspired by an idea of Gragnaniello et al. [14,15] we describe for
the ﬁrst time in the literature, the use of silicon injection, (Acquasil
Dent Sply Ultra Light Viscosity)® to simulate a lesion in the mid-
cheek area. Various materials have been tested to ﬁnd the most
similar to real tumor.
Aquasil Ultra LV is a quadrafunctional hydrophilic addition re-
action silicon, light body, with excellent hydrophilic properties,
dimensional accuracy, high tear strength and resistance to per-
manent deformation. This silicon has an important characteristic;
the similar consistency of the tumor, and it causes displacement of
surrounding structures with non-adhesive nature. This leaves the
surgical corridor undisturbed for performing the dissection.
This silicon presents a unique viscoelastic characteristics: liquid,
initially and than it expands when injected, forming a solid tumor
like structure, which allowed us to easily identify the tumor under
endoscopic guidance, and remove easily, preserving the noble
structures.5. Conclusion
In comparison to established techniques the major difference of
the proposed procedures is the small incision accompanied with a
great surgical windows that allowed the surgeon to see and pre-
serve the key anatomic structures. The surgical protocol presented
comprises three advantages: minimal skin incision compared with
the open surgery. Through the use of the endoscope it was possible
to see the noble structures and so not to damage them during the
removal of the tumor.
With the help of the transcutaneous injection of silicone, we
were able to simulate a tumor mass in the midcheek compartment
and its removal through endoscopy. Finally, thanks to this protocol
it's possible to train young surgeons during the anatomic dissec-
tions and, give the opportunity to become familiar with the
G. Dell' Aversana Orabona et al. / Surgical Oncology 26 (2017) 286e289 289endoscopic technique for the removal of midcheek mass.
Further clinical applications are required in order to assess ad-
vantages and/or limitations of this procedure.
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